Skip to main content

Table 5 Process and outcome measures used in Project ReD CHiP

From: A multi-level system quality improvement intervention to reduce racial disparities in hypertension care and control: study protocol

Type Measure+ Notes and definitions
Primary process measure % with uncontrolled BP with medication titration in last 3 months Uncontrolled BP ≥140/≥90 (or ≥130/≥80 if DM or chronic kidney disease); titration can be dose increase or medication change/addition
Secondary process measures % with BP measure in EMR in last 12 months  
% with history of pre-HTN with BP measure in last 12 months Two clinic BPs ≥120-<140≥80-<90; not on HTN medication
% with HTN with measure in last 6 months Two clinic BP ≥140/≥90 OR use of a HTN medication OR ICD9 diagnosis (401.xx)
% with HTN on a thiazide diuretic  
% with HTN and DM on ACE-I or ARB DM defined by ICD9 code 250.xx
% with lipid panel performed in last 5 years* May not be possible as EMR only in all clinics since March 2006
% with BP≥135/≥85 screened for DM in last 5 years* May not be possible as EMR only in all clinics since March 2006
Implementation uptake process measures % with BP measured with OMRON  
% of SBP and DBP measures ending in zero  
% of eligible patients enrolled in care management  
% completion rate for those enrolled in care management  
Provider behavioral intention related to assessment and partnership skills Measured at completion of the website review and at 6 months post-intervention
Change in provider self-reported use of assessment and partnership behaviors Measured before the website review and at 6 months post-intervention
% of providers receiving web training at each site Measured at 6 months post-intervention
Provider self-reported use of HTN dashboard Measured at 6 months post-intervention
Primary outcome measure % with controlled BP Controlled BP defined as <140/<90 (or <130/<80 if DM or chronic kidney disease present)
Secondary outcome measures % with controlled LDL Controlled LDL defined as <130 (or <100 if DM or coronary artery disease)
% with controlled HDL Controlled HDL defined as >50 in women or >40 in men
% with controlled triglycerides Controlled triglycerides defined as <150
% with controlled A1C Controlled A1C defined as <7.0
  Mean SBP, DBP, LDL, HDL, triglycerides, A1C  
  1. +Data are aggregated in one week intervals at baseline, during and after intervention roll-out for a minimum of 24 weeks.
  2. *These measures will only be performed in clinics that have had the EMR system in place for at least 5 years.
  3. Abbreviations: % percent, BP blood pressure, DM diabetes mellitus, EMR electronic medical record; HTN hypertension, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low density lipoprotein, HDL high density lipoprotein, A1C glycated hemoglobin.
Back to article page

Implementation Science

ISSN: 1748-5908